zollinger-ellison%20syndrome
ZOLLINGER-ELLISON SYNDROME
Zollinger-Ellison syndrome (ZES) is a disease entity which refers to the triad of severe peptic ulcer disease (PUD), gastric acid hypersecretion and non-beta cell gastrin-secreting tumor primarily of the pancreas and duodenum (gastrinoma).
Approximately two-thirds of patients have sporadic ZES while the rest is part of multiple endocrine neoplasia type 1.
ZES should be considered in the differential diagnoses of patients who present with abdominal pain, malabsorption and chronic watery diarrhea.
A high index of clinical awareness is necessary to correctly diagnose ZES.

Zollinger-Ellison Syndrome Drug Information

Drug Information

Indication: Short-term use for symptomatic improvement & healing of GI diseases requiring GI reduction eg, duodenal &a...

Indication: 20 mg Mild reflux disease & associated symptoms eg, heartburn, acid regurgitation, pain on swallowing. Lon...

Indication: Gastric, duodenal & stomal ulcer, reflux esophagitis. Relief of reflux-like symptoms eg, heartburn &/o...

Indication: Duodenal, benign gastric & post-op ulcer, Zollinger-Ellison syndrome, systemic mastocytosis, reflux oesoph...

Indication: Duodenal & gastric ulcer, GERD (including heartburn & peptic oesophagitis), persistent dyspepsia &...

Indication: Duodenal & gastric ulcer, NSAID-associated gastric acid & duodenal ulcers or erosions, H pylori eradic...

Indication: Duodenal & gastric ulcer, reflux esophagitis & Zollinger-Ellison syndrome.

Indication: Short-term use for symptomatic improvement & healing of GI diseases which require acid secretion reduction...

Dosage: Tab Adult Duodenal & gastric ulcers 300 mg daily for 4-8 wk. Maintenance: 150 mg at bedtime. GERD 150 mg b

Indication: Duodenal & benign gastric ulcer; Zollinger-Ellison syndrome; GERD.

2  /  7
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Jul 2019
Zinc or multivitamin supplements do not appear to suppress systemic inflammation nor reduce markers of environmental enteric dysfunction (EED) in infants, a recent Tanzania study has found.